Bio Protocol (@BioProtocol): Bio Weekly: The First Launches on Bio V1, Lab Livestream, Hacking the Microbiome, Patient #1 Study

Bio Weekly: The First Launches on Bio V1, Lab Livestream, Hacking the Microbiome, Patient #1 Study Last week's updates from the Biosphere: 🧪 The First Launches on Bio V1 The first pre-sale fundraises on Bio V1 are concluding this week: MycoDAO and SpineDAO. Myco ends this Monday, May 12, while Spine ends this Thursday, May 15. If the minimum funding thresholds are reached, both tokens will go live for trading within hours of their pre-sales concluding. Unlike previous fundraises where participants were 100% liquid from the time of the TGE, participants in Bio V1 pre-sales will receive 30% of their tokens immediately and 70% unlocking linearly over 1-month. Learn more. Meanwhile, BIO Curators who pledged their BIO tokens to the sales in exchange for the most favorable pre-sale valuation will vest over 6 months with a 3-month cliff. To deter bot activity, a 5% withdrawal fee was introduced, as well as withdrawal lock in the final 24 hours of the MycoDAO & SpineDAO auctions - Learn more. Both MycoDAO and SpineDAO are leveraging decentralized AI and BioAgents to power accelerated scientific discovery, enabling revenue-generating products that utilize DAO-owned patient and R&D datasets. 👉 Join the MycoDAO pre-sale here; and the SpineDAO pre-sale here. 😷 Long COVID Labs Patient #1 Case Study Long COVID Labs reported that Patient #1 in their case study experienced an 80% reduction in brain fog and 50–70% improvement in sleep and inflammation after six days. The patient also reported a worsening of post-exertional malaise, which may be linked to an immune response. Learn more. 🌐 Network Updates VitaDAO's VITA-FAST project has dispatched new anti-aging chemicals for testing at Newcastle University. Curetopia is focusing research efforts on 10 rare diseases by end of Q2 and 30 ARS gene family diseases by Q4. Learn more and watch the first livestream lab meeting. Nootropics DAO unveiled Nexus, an AI-powered research engine utilizing decentralized nootropics data to facilitate drug discovery & community-driven research through token incentives. MicrobiomeDAO was announced as a new BioDAO, addressing the microbiome by leveraging prediction markets and decentralized data ownership, including initiatives like BiomeBanking. Learn more. Quantum Biology DAO outlined their plan to build a microscope for detecting quantum effects in living cells. They also began a three-stage E. coli experiment to study growth rates and gene expression under hypomagnetic conditions. ValleyDAO's April update highlighted their success in engineering yeast for sustainable cocoa butter production as well as advancements in their AI-driven platform for research translation, called Phlo. PsyDAO is developing a new psychedelic called DMXE. CryoDAO is scouting sites for their upcoming US-based Biostasis Foundation facility. HairDAO is releasing a new episode of Hairy Matters on the potential effects of creatine on hair loss. 🧬 Bio Community Updates Bio and VitaDAO held preliminary meetings with the Abu Dhabi Ministry of Health to explore fast-track clinical trials in the UAE. Protocol Labs joined as a sponsor of the Bio x AI Hackathon. Join the Bio Discord hackathon-chat to collaborate or submit a solo project before June 10, 2025, with over $125K in prizes up for grabs. On May 20, the Solana DeScience Fair at Accelerate 2025 will showcase Bio, VitaDAO, SpineDAO, Curetopia, Pump Science, Quantum Biology DAO and more - Sign up. A new episode of Bio's podcast, DeSci Pilled, went live with SpineDAO. DeSci was making waves at SynBioBeta. Speaker applications for DeSci Berlin are closing May 9 - Apply here. Keep up with everything Bio in our Telegram, Discord & Governance forum